Join Now

Category Archives: BioUtah News

bioMérieux Seeks FDA Authorization for Point-of-Care Vaginitis Test

By Natalie Themm | Published July 1, 2026

The automated PCR test provides results in 20 minutes to help clinicians diagnose common causes of vaginitis during a patient visit.

| Tagged | Comments Off on bioMérieux Seeks FDA Authorization for Point-of-Care Vaginitis Test

NUSANO COMPLETES MAJOR MILESTONE TOWARD COMMERCIAL RADIOISOTOPE PRODUCTION

By Natalie Themm | Published July 1, 2026

FIRST OF THREE STEPS TOWARD BRINGING NOVEL RADIOISOTOPE PRODUCTION PLATFORM ONLINE

| Tagged | Comments Off on NUSANO COMPLETES MAJOR MILESTONE TOWARD COMMERCIAL RADIOISOTOPE PRODUCTION

Fluidx Announces Continued Clinical Success with ULTRA Embolic Gel

By Natalie Themm | Published July 1, 2026

Novel gel embolic designed to give physicians greater control and consistency during embolization.

| Tagged | Comments Off on Fluidx Announces Continued Clinical Success with ULTRA Embolic Gel

Elevating Utah’s Bioscience Advantage at BIO 2026

By Denise Bell | Published June 25, 2026

BioUtah, alongside state and local partners, showcased Utah’s booming $22.6B+ life sciences sector at the BIO International Convention, June 22-25, at the San Diego Convention Center. Through the Utah Pavilion Exhibit, the delegation boosted the state’s global profile as a premier bioscience hub. A number of meetings with entrepreneurs and companies interested in Utah’s bio […]

| Tagged | Comments Off on Elevating Utah’s Bioscience Advantage at BIO 2026

SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders

By Natalie Themm | Published June 25, 2026

SINTX’s advanced ceramic manufacturing platform supports customers across multiple industries requiring high-performance materials.

| Tagged | Comments Off on SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders

SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY

By Natalie Themm | Published June 25, 2026

Aligns With Growing Focus on Early Identification and Management of Preterm Birth Risk

| Tagged | Comments Off on SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY

Myriad Genetics Expands Minimal Residual Disease Testing for Three Cancer Types

By Natalie Themm | Published June 25, 2026

The whole-genome sequencing assay is now available for breast, colorectal, and renal cancers following new clinical study results.

| Tagged | Comments Off on Myriad Genetics Expands Minimal Residual Disease Testing for Three Cancer Types

Canary Speech Brings Canary Ambient™ to the Zoom App Marketplace, Putting Real-Time Vocal Biomarker Insights Into Every Telehealth Visit

By Natalie Themm | Published June 25, 2026

AI-powered voice analysis is now available to clinicians directly inside Zoom, transforming routine telehealth conversations into early signals for behavioral and cognitive health

| Tagged | Comments Off on Canary Speech Brings Canary Ambient™ to the Zoom App Marketplace, Putting Real-Time Vocal Biomarker Insights Into Every Telehealth Visit

BioUtah and Utah’s Life Sciences Industry Take Center Stage with Pavilion at BIO International Convention

By admin | Published June 19, 2026

The Utah Pavilion will serve as a gathering place to help convention attendees discover the state’s vibrant life sciences industry and the sector’s unique culture of collaboration that drives innovation.

| Comments Off on BioUtah and Utah’s Life Sciences Industry Take Center Stage with Pavilion at BIO International Convention

Halia Therapeutics Secures FDA Fast Track for Ofirnoflast

By Natalie Themm | Published June 18, 2026

The designation follows encouraging Phase 2 clinical trial results.

| Tagged | Comments Off on Halia Therapeutics Secures FDA Fast Track for Ofirnoflast

Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million

By Natalie Themm | Published June 18, 2026

Proceeds from transaction to support advancement of Denali’s broad TransportVehicle™-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseases.

| Tagged | Comments Off on Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million

Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line

By Natalie Themm | Published June 18, 2026

Visit has included tour of Utah headquarters and automated manufacturing facilities ahead of planned technology transfer.

| Tagged , | Comments Off on Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line

A Special Thanks To Our Legacy and Platinum Elite Members